Cargando…
Osteochondral angiogenesis and increased protease inhibitor expression in OA
OBJECTIVE: Normal cartilage is resistant to vascular invasion and anti-angiogenic protease inhibitors may contribute to its avascular status. We hypothesized that dysregulated expression of four key anti-angiogenic protease inhibitors may contribute to increased osteochondral vascularity in osteoart...
Autores principales: | Fransès, R.E., McWilliams, D.F., Mapp, P.I., Walsh, D.A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders For The Osteoarthritis Research Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877870/ https://www.ncbi.nlm.nih.gov/pubmed/20060952 http://dx.doi.org/10.1016/j.joca.2009.11.015 |
Ejemplares similares
-
Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis
por: Walsh, David A., et al.
Publicado: (2010) -
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis
por: Mapp, P.I., et al.
Publicado: (2010) -
Relationship between structural pathology and pain behaviour in a model of osteoarthritis (OA)
por: Nwosu, L.N., et al.
Publicado: (2016) -
Sotrastaurin, a PKC inhibitor, attenuates RANKL‐induced bone resorption and attenuates osteochondral pathologies associated with the development of OA
por: Pang, Cong, et al.
Publicado: (2020) -
Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
por: Lin, Zixuan, et al.
Publicado: (2019)